KCAS Bio’s Ryan Darling, Associate Director of Mass Spectrometry Bioanalysis, will present at the SCIEX Summit 2026 on Wednesday, October 7, as part of Day 2 of the virtual event.
Advancing Ultrasensitive Bioanalysis for Complex Modalities
Ryan’s presentation, “Ultrasensitive multiplexed bioanalysis of complex modalities using the SCIEX 7500+ system: A CRO perspective,” will explore how multiplexed LC–MS/MS workflows can support the sensitive quantitation of increasingly complex therapeutic modalities.
His presentation will highlight approaches for analyzing antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs), siRNAs, and other biotherapeutics, with a focus on improving analytical efficiency while reducing the overall burden of complex bioanalytical workflows.
As therapeutic modalities continue to evolve, bioanalytical strategies must keep pace. Multiplexed workflows offer an opportunity to address challenging analytical requirements while generating high-quality data with greater efficiency.
Join Ryan at SCIEX Summit 2026
Ryan will speak on Wednesday, October 7, during Day 2: Advancing therapeutic development through analytical science. The session will be part of a day focused on analytical approaches for complex pharmaceutical and biopharmaceutical challenges, including bioanalysis, oligonucleotide quantification, and ADC characterization.
Register for SCIEX Summit 2026 and join Ryan and other industry experts for a closer look at emerging approaches in analytical science.
Use the link above to register for the event. Or, fill out the form below to speak directly with a scientist from KCAS Bio.